CTA
RMD icon

Colonial Trust Advisors’s ResMed RMD Stock Holding History

Colonial Trust Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Buy
+64
New +$13.3K ﹤0.01% 539
2024
Q3 		– Sell
-10
Closed -$1.94K – 767
2024
Q2 		$1.94K Sell
10
-2
-17% -$406 ﹤0.01% 679
2024
Q1 		$2.39K Sell
12
-15
-56% -$2.75K ﹤0.01% 781
2023
Q4 		$4.66K Buy
27
+15
+125% +$2.31K ﹤0.01% 619
2023
Q3 		$1.78K Buy
12
+11
+1,100% +$1.99K ﹤0.01% 735
2023
Q2 		$219 Hold
1
– – ﹤0.01% 876
2023
Q1 		$219 Hold
1
– – ﹤0.01% 859
2022
Q4 		$208 Buy
+1
New +$220 ﹤0.01% 867

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Colonial Trust Advisors's RMD Position: Q2 2026 in Review

Colonial Trust Advisors opened a new position in ResMed (RMD) in Q2 2026: 64 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #539 among its holdings. This is a return to the name: Colonial Trust Advisors previously reported a position in RMD as recently as Q2 2024.

Colonial Trust Advisors first reported a position in RMD in Q4 2022 and has held it in 8 quarters since. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Colonial Trust Advisors held 64 shares of ResMed worth $12.5K as of Q2 2026.
  • ResMed was a new Colonial Trust Advisors position in Q2 2026.
  • ResMed made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #539 holding.
  • Colonial Trust Advisors first reported a position in ResMed in Q4 2022 and has held it in 8 quarters since.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.